Business

Serum Institute vaccine: India may get most of initial ‘Covishield’ stockpile

Read more at www.businesstoday.in

India will benefit from the initial stockpile of about 40-50 million ‘Covishield’ vaccines developed by the Serum Institute of India (SII) once the company gets the regulatory approval to roll out the vaccine for the masses. After getting the green signal from the …

Read more at www.businesstoday.in

Show More

Related Articles

Back to top button